A novel synthetic compound that interrupts androgen receptor signaling in human prostate cancer cells

被引:18
|
作者
Lu, Shan
Wang, Amy
Lu, Shan
Dong, Zhongyun
机构
[1] Univ Cincinnati, Coll Med, Dept Internal Med, Cincinnati, OH 45267 USA
[2] Univ Cincinnati, Coll Med, Dept Pathol, Cincinnati, OH 45267 USA
关键词
D O I
10.1158/1535-7163.MCT-06-0735
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of this study was to determine the effects of 6-amino-2-[2-(4-tert-butyl-phenoxy)-ethylsulfonyl]-1H-pyrimidine-4-one 00), a novel synthetic compound with small-molecule drug properties, on androgen-regulated gene expression and cell growth in human prostate cancer cells. LNCaP, 22Rv1, and LAPC-4 cells were used in the studies. Expression of prostate-specific antigen (PSA) and androgen receptor (AR) was determined by ELISA, Western blotting, real-time reverse transcription-PCR, nuclear run-on, and/or promoter luciferase reporter assays. Effects of DL3 on cell growth were determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide staining. DL3 inhibited dihydrotestosterone (DHT)-induced PSA expression in a dose-dependent fashion. The inhibitory effects of DL3 were more potent than those of flutamide, nilutamide, and bicalutamide. Moreover, DL3 blocked the stimulatory effects of nilutamide on PSA expression in LNCaP cells. Unlike the three classic antiandrogens, DL3 did not show intrinsic AR agonist activity. Nuclear run-on and PSA promoter reporter assays revealed that DL3 blocked DHT-induced PSA gene transcription. Consistent with its effects on PSA expression, DL3 inhibited DHT-stimulated cell growth with a potency significantly superior to flutamide, nilutamide, or bicalutamide. Furthermore, cells resistant to flutamide or nilutamide were as susceptible as their parental counterparts to the inhibitory effects of DO on both PSA expression and cell growth. DL3 did not inhibit AR nuclear localization and the NH2- and COOH-terminal interaction of AR induced by DHT. These data show that DO is a novel inhibitor of the AR signaling axis and a potentially potent therapeutic agent for the management of advanced human prostate cancer.
引用
收藏
页码:2057 / 2064
页数:8
相关论文
共 50 条
  • [1] Curcumin interrupts the interaction between the androgen receptor and Wnt/β-catenin signaling pathway in LNCaP prostate cancer cells
    Choi, H. Y.
    Lim, J. E.
    Hong, J. H.
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2010, 13 (04) : 343 - 349
  • [2] Curcumin interrupts the interaction between the androgen receptor and Wnt/β-catenin signaling pathway in LNCaP prostate cancer cells
    H Y Choi
    J E Lim
    J H Hong
    [J]. Prostate Cancer and Prostatic Diseases, 2010, 13 : 343 - 349
  • [3] Complex regulation of human androgen receptor expression by Wnt signaling in prostate cancer cells
    Yang, X.
    Chen, M. -W.
    Terry, S.
    Vacherot, F.
    Bemis, D. L.
    Capodice, J.
    Kitajewski, J.
    de la Taille, A.
    Benson, M. C.
    Guo, Y.
    Buttyan, R.
    [J]. ONCOGENE, 2006, 25 (24) : 3436 - 3444
  • [4] Complex regulation of human androgen receptor expression by Wnt signaling in prostate cancer cells
    X Yang
    M-W Chen
    S Terry
    F Vacherot
    D L Bemis
    J Capodice
    J Kitajewski
    A de la Taille
    M C Benson
    Y Guo
    R Buttyan
    [J]. Oncogene, 2006, 25 : 3436 - 3444
  • [5] Androgen receptor activation by Gs signaling in prostate cancer cells
    Kasbohm, EA
    Guo, R
    Yowell, CW
    Bagchi, G
    Kelly, P
    Arora, P
    Casey, PJ
    Daaka, Y
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (12) : 11583 - 11589
  • [6] Androgen receptor signaling in prostate cancer
    Zoran Culig
    Frédéric R. Santer
    [J]. Cancer and Metastasis Reviews, 2014, 33 : 413 - 427
  • [7] Androgen receptor signaling in prostate cancer
    Culig, Zoran
    Santer, Frederic R.
    [J]. CANCER AND METASTASIS REVIEWS, 2014, 33 (2-3) : 413 - 427
  • [8] Unraveling the Complexities of Androgen Receptor Signaling in Prostate Cancer Cells
    Heemers, Hannelore V.
    Tindall, Donald J.
    [J]. CANCER CELL, 2009, 15 (04) : 245 - 247
  • [9] RhoGDIα Downregulates Androgen Receptor Signaling in Prostate Cancer Cells
    Zhu, Yezi
    Liu, Chengfei
    Tummala, Ramakumar
    Nadiminty, Nagalakshmi
    Lou, Wei
    Gao, Allen C.
    [J]. PROSTATE, 2013, 73 (15): : 1614 - 1622
  • [10] HO1 induction interrupts the glucocorticoid receptor signaling in prostate cancer cells
    Leonardi, Daiana B.
    Paez, Alejandra V.
    Schuster, Federico
    Anselmino, Nicolas
    Brandani, Javier N.
    Abbate, Mercedes
    Gueron, Geraldine
    Cotignola, Javier H.
    Vazquez, Elba S.
    [J]. CANCER RESEARCH, 2015, 75